Patent · US Expired

Practical synthesis of benzoxazinones useful as HIV reverse transcriptase inhibitors

US6348616B1 · kind B1 · utility

0Cited by
4References
2Claims
0Family size

Inventors

Key dates

Filing dateAug 30, 2000
Grant dateFeb 19, 2002
Priority date
Expiry dateAug 30, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/02
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention describes novel methods for the synthesis of benzoxazinone compounds which are useful as human immunodeficiency virus (HIV) reverse transcriptase inhibitors. The benzoxazinone of the formula: is particularly effective in the treatment of HIV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.